Aehr Test Systems (AEHR) slides as investors digest recent dilution and mixed quarterly results

Aehr Test Systems, Inc. (AEHR) is down 7.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to follow-through selling after Aehr’s recently completed at-the-market equity program, which increased share supply and can pressure the stock in the near term. The move also comes soon after the company’s fiscal Q3 results, where weaker revenue and a quarterly loss likely kept sentiment volatile despite strong bookings.

Details:

Aehr established an at-the-market offering program to sell up to $60 million of common stock, which can weigh on prices as the market anticipates incremental shares being issued.

The company later disclosed it fully utilized the program, reporting approximately $60 million of gross proceeds, reinforcing dilution concerns for some investors.

In its fiscal third quarter update (period ended February 27, 2026), Aehr posted revenue around $10.3 million and reported a loss for the quarter, a mix that can pressure shares even when longer-term demand is improving.

The same quarterly update highlighted over $37 million in bookings driven by AI and data center infrastructure demand, which may be supporting the stock longer term but did not prevent near-term profit-taking.

Sources:

Aehr Test Systems (press release), U.S. SEC (8-K/Prospectus filings), Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AEHR Insider Trading Activity

$AEHR insiders have traded $AEHR stock on the open market 48 times in the past 6 months. Of those trades, 0 have been purchases and 48 have been sales.

Here’s a breakdown of recent trading of $AEHR stock by insiders over the last 6 months:

GAYN ERICKSON (President and CEO) has made 0 purchases and 2 sales selling 152,824 shares for an estimated $10,786,791.
GEOFFREY GATES SCOTT (Director) has made 0 purchases and 5 sales selling 95,000 shares for an estimated $8,033,250.
RHEA J POSEDEL (Director) has made 0 purchases and 8 sales selling 100,504 shares for an estimated $7,619,263.
ALBERTO SALAMONE (EVP, PPBI BUSINESS) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,761,950.
VERNON ROGERS (Exec VP of Sales & Mktg.) has made 0 purchases and 5 sales selling 29,805 shares for an estimated $2,475,620.
DONALD P. II RICHMOND (CTO) has made 0 purchases and 2 sales selling 32,762 shares for an estimated $2,326,659.
HOWARD T SLAYEN (Director) has made 0 purchases and 2 sales selling 31,000 shares for an estimated $2,279,357.
FARIBA DANESH (Director) has made 0 purchases and 3 sales selling 18,500 shares for an estimated $1,406,628.
ADIL ENGINEER (Chief Operating Officer) has made 0 purchases and 4 sales selling 16,813 shares for an estimated $1,139,350.
LAURA OLIPHANT (Director) has made 0 purchases and 8 sales selling 13,927 shares for an estimated $887,013.
ALISTAIR N SPORCK (VP Contactor Business Unit) has made 0 purchases and 5 sales selling 9,000 shares for an estimated $568,196.
DIDIER WIMMERS (Executive VP of R&D) has made 0 purchases and 2 sales selling 5,400 shares for an estimated $385,731.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$AEHR Hedge Fund Activity

We have seen 90 institutional investors add shares of $AEHR stock to their portfolio, and 73 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

HALTER FERGUSON FINANCIAL INC. removed 627,498 shares (-97.7%) from their portfolio in Q1 2026, for an estimated $23,267,625
WELLINGTON MANAGEMENT GROUP LLP added 469,400 shares (+129.9%) to their portfolio in Q4 2025, for an estimated $9,477,186
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 398,389 shares (-44.6%) from their portfolio in Q4 2025, for an estimated $8,043,473
INVESCO LTD. removed 338,351 shares (-92.3%) from their portfolio in Q4 2025, for an estimated $6,831,306
NEXT CENTURY GROWTH INVESTORS LLC added 276,160 shares (+99.9%) to their portfolio in Q4 2025, for an estimated $5,575,670
TWO SIGMA INVESTMENTS, LP added 250,247 shares (+237.6%) to their portfolio in Q4 2025, for an estimated $5,052,486
JANE STREET GROUP, LLC added 240,438 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,854,443

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$AEHR Analyst Ratings

Wall Street analysts have issued reports on $AEHR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

William Blair issued a "Outperform" rating on 03/02/2026

To track analyst ratings and price targets for $AEHR, check out Quiver Quantitative's $AEHR forecast page.

$AEHR Price Targets

Multiple analysts have issued price targets for $AEHR recently. We have seen 2 analysts offer price targets for $AEHR in the last 6 months, with a median target of $25.0.

Here are some recent targets:

Christian Schwab from Craig-Hallum set a target price of $21.0 on 01/09/2026
An analyst from Lake Street set a target price of $29.0 on 12/17/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.